Search Results
10
Everything
FMC Shareholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action Against FMC Corporation
February 25, 2025 17:58 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that FMC Corporation (FMC) Misled Investors Regarding its Business Prospects
GSK PLC Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against GSK
February 06, 2025 19:48 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that GSK PLC (GSK) Misled Investors Regarding its Recall of Zantac
DMC Global Inc. Stockholders Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Class Action Against BOOM
January 24, 2025 16:51 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that DMC Global Inc. (BOOM) Misled Investors Regarding its Operations and Financial Results
FTAI Aviation Ltd. Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against FTAI
January 24, 2025 16:15 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that FTAI Aviation Ltd. (FTAI) Misled Investors by Manipulating its Financial Statements
BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the BIOA Class Action
January 17, 2025 17:29 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
Transocean Ltd. Shareholders are Encouraged to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the RIG Class Action
January 13, 2025 21:21 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Transocean Ltd. (RIG) Misled Investors Regarding its Business Prospect
Stockholder Notice: Robbins LLP Informs Stockholders of the Micron Technology, Inc. Class Action Lawsuit
January 13, 2025 21:07 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Micron Technology, Inc. (MU) Failed to Disclose Decreased Demand for its Products.
AZN Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the AstraZeneca PLC Class Action
January 13, 2025 19:49 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that AstraZeneca PLC (AZN) Misled Investors Regarding its Legal Exposure in China
Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action
January 08, 2025 18:46 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
Robbins LLP Reminds Investors of the Pending Class Action Against Symbotic Inc. and Urges SYM Stockholders to Seek Legal Counsel
January 06, 2025 21:28 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Symbotic Inc. (SYM) Failed to Disclose Material Weaknesses in its Internal Control Over Financial Reporting